|
The OAML's Guidelines for Clinical Laboratory Practice are
intended to support improved patient outcomes by encouraging
better-informed, clinically relevant decisions about laboratory
test ordering and more effective use of health care resources.
The OAML, through
its Quality Assurance of Clinical Laboratory Practice Committee
co-ordinates the development and dissemination, implementation
and evaluation of Guidelines for Clinical Laboratory Practice.
A proposed guideline
is developed by a working group of the Committee with input
from outside experts. The proposed guideline is then submitted
to the Committee as a whole and comments are incorporated
into a revision of the document. This draft is submitted to
laboratory Medical Directors, professional associations and
other representatives of end users for additional comment.
The guideline may be revised in light of these comments and
submitted to the OAML Board of Directors for approval.
Approved Guidelines
are distributed to Community Laboratories and by them to their
client physicians and other practitioners ordering laboratory
tests. There may be additional educational materials produced,
if it is thought they might be useful, and these are distributed
with the guideline.
The comments of
end users are essential to the development of guidelines that
will encourage adherence. You are strongly encouraged to submit
your comments on any OAML Guideline to:
Judy Ash
Director, Programs & Member Services
Ontario Association of Medical Laboratories
5160 Yonge Street, Suite 710
Toronto, Ontario M2N 6L9
For a list of all OAML Guidelines, please click here.
|
